Remergify's Flagship Wallet Product to Eliminate $1.4 Billion Annual Scam Vector Through Identity-Based Transfer Technology ...

Organisations need to rethink speed, automation and identity risk as artificial intelligence (AI) continues to amplify ...

Findings from a phase I trial (NCT04183166) evaluating TG4050, a neoantigen therapeutic vaccine, in patients with operable, ...

Remergify's Flagship Wallet Product to Eliminate $1.4 Billion Annual Scam Vector Through Identity-Based Transfer Technology MIAMI, FLORIDA / ACCESS Newswire / January 12, 2026 / Remergify, Inc., a lea ...

India has an estimated 378 million young people, nearly two-thirds of whom live in rural areas. Yet despite accounting for ...

Asimov, the synthetic biology company advancing the design and manufacture of therapeutics, and AGC Biologics, your friendly CDMO expert, have signed a licensing agreement for Asimov’s off-the-shelf ...

The French and U.K. equivalents to the U.S. government’s cyber defense agency have issued new advice for users. “Deactivate ...

Top 10 tech stocks of 2025 ranked by price action and fundamentals—why memory, storage & energy are key AI bottlenecks. Click ...

Uttar Pradesh's CM Yogi Adityanath claims the state now matches national health averages, emphasizing AI's role in ...

Jerome Powell isn’t known for his expressiveness. The chair of the Federal Reserve has kept quiet over the past year as ...

Detailed price information for Theralase Technologies Inc (TLTFF) from The Globe and Mail including charting and trades.

For 30-year-old Nirmala, leadership wasn’t a goal - it was born out of necessity. Married before she turned 18, Nirmala ...